Monday 07 October 2024

BioHarvest announces imminent launch of Vinia functional coffee

Company to host Virtual Shareholder Update on December 13, 2023, to discuss the Q3 2023 financials announced November 29, and provide additional information regarding the VINIA coffee launch and other major VINIA marketing programs and upcoming new product pipeline

Must read

  • Dalla Corte
  • TME - Cialdy Evo
Demuslab

VANCOUVER, British Columbia, Canada and REHOVOT, Israel – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) announces that it is hosting the Q3 Performance Update Presentation on Wednesday, December 13, 2023, at 11:30 am PST | 2:30 pm EST. The interactive session will be hosted by Ilan Sobel, CEO of BioHarvest Sciences.

“I am currently in Nashville, Tennessee, as part of a U.S. media and operational partner tour ahead of the imminent launch of our VINIA functional coffee, and I am energized by the positive and committed feedback I am receiving as I meet with our marketing, commercial, and investor partners,” stated CEO Ilan Sobel, adding “As announced in our Q3 financials this week, we have achieved double-digit revenue growth quarter-over-quarter, we have improved our gross profit margins, and we are actively planning the launches of disruptive new products.

I look forward to hosting the December 13 Shareholder Update and to answering questions from several hundred of our energized shareholder partners while enjoying a fresh mug of our delicious new VINIA coffee.”

Mr. Sobel will discuss the Q3 2023 financials announced November 29, and he will provide additional information regarding the VINIA coffee launch and other major VINIA marketing programs and upcoming new product pipeline.

Following the presentation, there will be a live question and answer session. All media and investors are invited to pre-register. For any questions regarding the event, please contact info@bioharvest.com.

Link to register: https://us02web.zoom.us/webinar/register/WN_bLZXtZR3T9ijR_uqmdJA_w

  • La Cimbali

Q3 Corporate Highlights released November 29:

  • Q3 VINIA revenues of USD 3.24M represent growth of 113% compared to Q3 2022 and 18% increase compared to Q2 2023
  • Year over Year Q3 Gross Profit improved from 18% to 45%
  • Q4 2023 revenue range guidance of USD 4.2M – 4.5M
  • VINIA total active subscriber count grew by 213% Year over Year

About BioHarvest Sciences

BioHarvest Sciences Inc. (CSE: BHSC) is a fast-growing Biotech firm listed on the Canadian Securities Exchange. BioHarvest has developed a patented bio-cell growth platform technology capable of growing the active and beneficial ingredients in fruit and plants, at an industrial scale, without the need to grow the plant itself.

BioHarvest is currently focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions, within two major business verticals – nutraceutical health and wellness products such as dietary supplements, and development of plant cell-based Active Pharmaceutical Ingredients (API’s) that focus on specific medical indications.

CIMBALI

Latest article

  • Franke Mytico
  • Gimoka
  • DESCAMEX COFFELOVERS 2024
Demus Art of decaffeination